phase readout
saveNCT07251582: Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
RECRUITINGupdated 1h ago
community read0 votes
Sponsor: Hunan Province Tumor Hospital. Phase: PHASE3. Conditions: Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
view source ↗
comments(0)
5-min edit window · permanent after that